Literature DB >> 29158458

Response to "The importance of study design in the assessment of nonnutritive sweeteners and cardiometabolic health".

Meghan B Azad1, Dylan S MacKay2, Ryan Zarychanski3.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 29158458      PMCID: PMC5698034          DOI: 10.1503/cmaj.733441

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Consumption of Low-Calorie Sweeteners among Children and Adults in the United States.

Authors:  Allison C Sylvetsky; Yichen Jin; Elena J Clark; Jean A Welsh; Kristina I Rother; Sameera A Talegawkar
Journal:  J Acad Nutr Diet       Date:  2017-01-10       Impact factor: 4.910

Review 2.  Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies.

Authors:  Meghan B Azad; Ahmed M Abou-Setta; Bhupendrasinh F Chauhan; Rasheda Rabbani; Justin Lys; Leslie Copstein; Amrinder Mann; Maya M Jeyaraman; Ashleigh E Reid; Michelle Fiander; Dylan S MacKay; Jon McGavock; Brandy Wicklow; Ryan Zarychanski
Journal:  CMAJ       Date:  2017-07-17       Impact factor: 8.262

3.  The importance of study design in the assessment of nonnutritive sweeteners and cardiometabolic health.

Authors:  John L Sievenpiper; Tauseef A Khan; Vanessa Ha; Effie Viguiliouk; Rodney Auyeung
Journal:  CMAJ       Date:  2017-11-20       Impact factor: 8.262

Review 4.  Evidence for Health Decision Making - Beyond Randomized, Controlled Trials.

Authors:  Thomas R Frieden
Journal:  N Engl J Med       Date:  2017-08-03       Impact factor: 91.245

Review 5.  Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews.

Authors:  Daniele Mandrioli; Cristin E Kearns; Lisa A Bero
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.